tiprankstipranks
Trending News
More News >

Decibel downgraded to Market Perform from Outperform at SVB Securities

SVB Securities analyst Mani Foroohar downgraded Decibel Therapeutics to Market Perform from Outperform with a price target of $2, down from $7. The firm cites uncertainty for the partnering opportunity for DB-020 and broader concerns regarding cash burn and runway for the downgrade, the analyst tells investors in a research note.

Confident Investing Starts Here:

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on DBTX:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue